‘Hope And Scientific Spillover’ – Cross-Atlantic HTA Alliance To Focus On Novel Benefits

 
• By Francesca Bruce
  
The first guidance to be delivered by the HEMA HTA collaboration will help HTAs analyze the value of drugs by considering novel treatment benefits.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Pink Sheet

More from Health Technology Assessment